Showing results (241-250 of 315) with videos related to

Sort By:
Pageof 32
The Journal of Clinical Endocrinology and Metabolism|February 17, 2021
Fasting Plasma GLP-1 Is Associated With Overweight/Obesity and Cardiometabolic Risk Factors in Children and AdolescentsSara E Stinson, Anna E Jonsson, Morten A V Lund, et al.
The Journal of Clinical Endocrinology and Metabolism|February 21, 2020
GIP and GLP-1 Receptor Antagonism During a Meal in Healthy IndividualsLærke S Gasbjerg, Mads M Helsted, Bolette Hartmann, et al.
Diabetes|December 8, 2022
The Importance of Endogenously Secreted GLP-1 and GIP for Postprandial Glucose Tolerance and β-Cell Function After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy SurgeryMorten Hindsø, Nora Hedbäck, Maria S Svane, et al.
The Journal of Clinical Endocrinology and Metabolism|June 12, 2024
Glycodeoxycholic Acid Inhibits Primary Bile Acid Synthesis With Minor Effects on Glucose and Lipid Homeostasis in HumansEmma C E Meessen, Soumia Majait, Ümran Ay, et al.
British Journal of Pharmacology|December 2, 2021
Novel agonist and antagonist radioligands for the GLP-2 receptor. Useful tools for studies of basic GLP-2 receptor pharmacologySarina Gadgaard, Wijnand J C van der Velden, Sine P Schiellerup, et al.
European Journal of Endocrinology|April 22, 2021
Effects of endogenous GIP in patients with type 2 diabetesSigne Stensen, Lærke S Gasbjerg, Liva L Krogh, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 1, 2026
The effect of ghrelin on insulin sensitivity and beta-cell function after sleeve gastrectomyMarie-Louise Dichman, Nora Hedbäck, Amalie London, et al.
ACS Pharmacology & Translational Science|February 22, 2021
GLP-1 Val8: A Biased GLP-1R Agonist with Altered Binding Kinetics and Impaired Release of Pancreatic Hormones in RatsWijnand J C van der Velden, Florent X Smit, Charlotte B Christiansen, et al.
Cell Metabolism|November 20, 2018
Neuromedin U Does Not Act as a Decretin in RatsRune Ehrenreich Kuhre, Charlotte Bayer Christiansen, Seyed Mojtaba Ghiasi, et al.
Diabetologia|March 11, 2025
Rare MTNR1B variants causing diminished MT2 signalling associate with elevated HbA1c levels but not with type 2 diabetesKimmie V Sørensen, Johanne M Justesen, Lars Ängquist, et al.
Pageof 32